Serge Bodart of IDDI provides insight on the pharma and biopharma trends impacting CROs, outsourcing in today’s market, and advances in clinical research.
New streams of real-world data from electronic health records and other data sources, with advances in ML, will be crucial for creating next-gen clinical trials
Jennifer Bradford, Ph.D., Head of Data Science at PHASTAR08.19.19